Medicare Part D faces significant plan reductions and rising costs in 2026. Beneficiaries must review their drug plans before the December 7 deadline to avoid premium hikes and coverage losses.
An Everett-based lab operator was sentenced to prison for a $1.17M Medicare fraud scheme involving fraudulent billing for unperformed COVID-19 and respiratory tests. The case underscores ongoing regulatory challenges.
The Department of Health and Human Services ends the Richardson Waiver, impacting public notice and comment in healthcare rulemaking. Industry groups express concerns over transparency and stakeholder engagement.
Rising Medicare premiums, deductibles, and coinsurance rates in 2026 increase retiree healthcare expenses. Medicare supplemental insurance can help manage these escalating costs.
CMS introduces ACCESS model to enhance technology-supported care and outcome-based payments for Medicare patients with chronic conditions starting in 2026.
Medicare beneficiaries face higher Part B premiums, fewer Part D plans, and Medicare Advantage cancellations in 2026, making open enrollment critical for coverage decisions.
Learn about key changes to Medicare in 2026 including rising Part B premiums, fewer Part D plans, and the impact of Medicare Advantage plan cancellations on beneficiaries. Understand market trends and enrollment advice.
As the December 7 Medicare open enrollment deadline approaches, Medicare Advantage plans face market disruptions causing confusion and potential coverage gaps for beneficiaries in 2026.
CMS releases the Calendar Year 2026 OPPS-ASC Final Rule, impacting Medicare reimbursement rates for hospital outpatient services, radiopharmaceuticals, and 340B drug pricing.
The Supreme Court examines presidential authority under IEEPA to impose tariffs amid debate on their fiscal impact on Social Security, Medicare, and national debt. Economic analysis highlights limited revenue benefits and significant economic drawbacks.
